JP2009521932A5 - - Google Patents

Download PDF

Info

Publication number
JP2009521932A5
JP2009521932A5 JP2008548779A JP2008548779A JP2009521932A5 JP 2009521932 A5 JP2009521932 A5 JP 2009521932A5 JP 2008548779 A JP2008548779 A JP 2008548779A JP 2008548779 A JP2008548779 A JP 2008548779A JP 2009521932 A5 JP2009521932 A5 JP 2009521932A5
Authority
JP
Japan
Prior art keywords
polypeptide
variant
fragment
nucleic acid
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008548779A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009521932A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/049637 external-priority patent/WO2007076162A2/en
Publication of JP2009521932A publication Critical patent/JP2009521932A/ja
Publication of JP2009521932A5 publication Critical patent/JP2009521932A5/ja
Pending legal-status Critical Current

Links

JP2008548779A 2005-12-29 2006-12-29 抗菌性カテリシジンペプチド Pending JP2009521932A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75487805P 2005-12-29 2005-12-29
PCT/US2006/049637 WO2007076162A2 (en) 2005-12-29 2006-12-29 Antimicrobial cathelicidin peptides

Publications (2)

Publication Number Publication Date
JP2009521932A JP2009521932A (ja) 2009-06-11
JP2009521932A5 true JP2009521932A5 (https=) 2010-02-18

Family

ID=38218737

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008548779A Pending JP2009521932A (ja) 2005-12-29 2006-12-29 抗菌性カテリシジンペプチド

Country Status (8)

Country Link
US (1) US7985832B2 (https=)
EP (1) EP1966235A4 (https=)
JP (1) JP2009521932A (https=)
CN (1) CN101351474A (https=)
AU (1) AU2006330769A1 (https=)
BR (1) BRPI0621148A2 (https=)
CA (1) CA2632782A1 (https=)
WO (1) WO2007076162A2 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006330769A1 (en) * 2005-12-29 2007-07-05 Kansas State University Research Foundation Antimicrobial cathelicidin peptides
JP2009535027A (ja) * 2006-04-27 2009-10-01 シンガポール ヘルス サービシーズ ピーティーイー リミテッド 抗菌ペプチド
US8710272B2 (en) 2007-01-08 2014-04-29 Androscience Corporation Compounds with (1 E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
US9000222B2 (en) 2007-01-08 2015-04-07 Androscience Corporation Compounds with (1E, 6E)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione structural scaffold, their biological activity, and uses thereof
AU2008205312B2 (en) 2007-01-08 2013-11-21 Annji Pharmaceutical Co., Ltd. Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof
MX2010001125A (es) 2007-07-31 2010-09-30 Androscience Corp Composiciones incluyendo receptor androgeno de degradacion (ard) ponteciadores y metodos de tratamiento profilactico o terapeutico de trastornos de la piel y la caida de cabello.
AU2008310076A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag CGRP as a therapeutic agent
KR20100061481A (ko) * 2007-09-11 2010-06-07 몬도바이오테크 래보래토리즈 아게 치료제로서의 미니가스트린
CA2776883A1 (en) * 2009-06-16 2010-12-23 George Mason Intellectual Properties, Inc. Antimicrobial and antibiofilm activity of cathelicidins
AU2010306940A1 (en) 2009-10-12 2012-06-07 Smith, Larry Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
US10174081B2 (en) * 2011-04-21 2019-01-08 George Mason Research Foundation, Inc. Antimicrobial peptides and uses therefore
CN104010653B (zh) 2011-10-31 2019-01-01 凯恩生物科技有限公司 用于预防并治疗口腔疾病的组合物和方法
WO2015196299A1 (en) * 2014-06-27 2015-12-30 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products
US11723852B2 (en) 2011-10-31 2023-08-15 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products
US10357470B2 (en) 2013-03-07 2019-07-23 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof
US10046137B2 (en) 2014-02-21 2018-08-14 Avadim Technologies, Inc. Method for maintenance of urethral catheters
ES2789351T3 (es) 2015-01-13 2020-10-26 Hope City Máscaras de enlace peptídico de proteínas de unión a CTLA4
CN104830891B (zh) * 2015-03-23 2017-10-31 广东药科大学 一种金环蛇抗菌肽Cath‑BF30的高效制备方法
US20190352377A1 (en) * 2016-11-15 2019-11-21 The Rockefeller University Chimeric antibodies comprising binding domains of phage lysins, bacterial autolysins, bacteriocins, and phage tail or tail fibers
CN109996554B (zh) * 2016-11-21 2024-03-29 匹兹堡大学联邦高等教育系统 新型抗微生物和抗癌疗法
CN109266655B (zh) * 2018-09-06 2021-11-09 浙江大学 一种抗菌肽及其原核表达方法和应用
CA3143518A1 (en) * 2019-06-12 2020-12-17 Avadim Health Ip, Inc. Compositions and methods for the antiseptic cleansing and biofilms treatment of mammalian tissue
CN110590927B (zh) * 2019-09-17 2022-06-14 济宁医学院 多疣壁虎抗氧化肽及其应用
CN111374317B (zh) * 2019-12-18 2022-08-30 苏州大学 一种天然抗菌肽Hc-CATH在食品防腐保鲜中的应用
CN111374169B (zh) * 2019-12-18 2022-08-30 苏州大学 一种天然抗菌肽As-CATH5在食品防腐保鲜中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830993A (en) * 1995-04-10 1998-11-03 Kansas State University Research Foundation Synthetic antimicrobial peptide
US20030022829A1 (en) * 2001-03-30 2003-01-30 Wendy Maury Novel antiviral activities primate theta defensins and mammalian cathelicidins
US7173007B1 (en) * 2003-04-02 2007-02-06 The Regents Of The University Of California Therapy for microbial infections
US7776823B2 (en) * 2003-10-21 2010-08-17 The Regents Of The University Of California Human cathelicidin antimicrobial peptides
CN1878789A (zh) 2003-10-21 2006-12-13 加利福尼亚大学董事会 人凯萨林菌素抗微生物肽
US7485619B2 (en) * 2005-01-31 2009-02-03 Yeon Sook KIM Antimicrobial agent
KR101326133B1 (ko) 2005-03-10 2013-11-06 삼성디스플레이 주식회사 평판 표시 장치 제조 시스템
US8202835B2 (en) * 2005-06-17 2012-06-19 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
AU2006330769A1 (en) * 2005-12-29 2007-07-05 Kansas State University Research Foundation Antimicrobial cathelicidin peptides
EP2200628A2 (en) * 2007-07-15 2010-06-30 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors

Similar Documents

Publication Publication Date Title
JP2009521932A5 (https=)
Brogden et al. Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?
Nuti et al. Antimicrobial peptides: a promising therapeutic strategy in tackling antimicrobial resistance
Wu et al. Effects of cations and pH on antimicrobial activity of thanatin and s-thanatin against Escherichia coli ATCC25922 and B. subtilis ATCC 21332
CN107735098B (zh) 抗微生物疗法
CN102482655A (zh) 抗微生物剂
Regmi et al. Antimicrobial peptide isolated from Bacillus amyloliquefaciens K14 revitalizes its use in combinatorial drug therapy
JP2023517245A5 (https=)
JP2012526771A (ja) 抗真菌性ペプチドを含有する医薬組成物
US11649267B2 (en) Mitrecin A polypeptide with antimicrobial activity
CN106636050A (zh) 来源于耐甲氧西林金黄色葡萄球菌噬菌体的宽谱内溶素及其应用
RU2009134510A (ru) Рекомбинантный химерный белок фактора ингибирования нейтрофилов и гиругена и содержащая его фармацевтическая композиция
JP2012504958A5 (https=)
RU2014109402A (ru) ПРОДУЦИРУЕМЫЙ БАКТЕРИЯМИ МИКРОЦИН С, НОВЫЙ АНТИМИКРОБНЫЙ ПЕПТИД, ЭФФЕКТИВНЫЙ ПРОТИВ ПАТОГЕННЫХ МИКРООРГАНИЗМОВ, НАПРИМЕР ЭНТЕРОГЕМОРРАГИЧЕСКОЙ Escherichia coli (EHEC)
JP2017533177A5 (https=)
US7173007B1 (en) Therapy for microbial infections
JP2017533177A (ja) スイギュウ由来ペプチド抗生物質療法
CN115043924A (zh) 一种改造体抗菌肽及其应用
CN102018101A (zh) 一种南美白对虾抗菌肽制剂及其在水产养殖中的应用
KR102019153B1 (ko) 돌돔 유래의 항균 펩타이드 및 그의 용도
CN116063440B (zh) 一种可口革囊星虫抗菌肽及其应用
CN116143882A (zh) 一种三斑海马hepcidin抗菌肽及其应用
CN101817871B (zh) 迟缓爱德华氏菌密度感应系统阻断因子及其构建和应用
CN100345865C (zh) 一种抗菌二肽及其化学修饰物、制备方法与应用
CN104945494B (zh) 一种赤链华游蛇来源抗菌多肽sac及应用